On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

Pharmacy benefit managers actually "play a vital role in holding" sometimes-inflated prices down, said UHG CEO Andrew Witty ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

Known as the middlemen of the pharma industry, PBMs play an intermediary role between health insurers, pharmacies and ...

Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...